Healthcare Program Enrolls 10,000 Patients in Diabetes and Hypertension Care
Nairobi, Kenya, March 16, 2026 — The Access to Healthcare program by Boehringer Ingelheim, implemented in partnership with mPharma, has surpassed a major milestone after enrolling more than 10,000 new patients into long-term care for hypertension and type 2 diabetes. Launched in 2022, the program reached more than 150,000 people across Kenya in the past…


